Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icariin Soft Capsules + TACE as Adjuvant Therapy for HCC
NCT06900478Phase 2Not yet recruiting
- Sponsor
- Hua Medicine
- Start
- Mar 2025
- Primary completion
- Jun 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of icariin in hepatocellular carcinoma (HCC), sponsored by Hua Medicine. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
icariin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT06900478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06900478.